Member Info for ant15

Shares and warrants instead of cash. Its minimal dilution and demonstrates faith in the Company's future prospects. Its not only this drill and The Helium that Turner Pope clearly have eyes on . Good news and just rewards for getting the company to where it is now. Poised for greater things!

Been in since Rose days . Pleased to see that yesterdays rise wasn't eroded by early profit takers, at least to any meaningful extent. Next couple of weeks will be very interesting More so than ever before. Right crew for a high pressure target that could a yield real rise in the price. GLA LTH's

I am somewhat confused by what I also see as a trading pattern. Strange to say the least!

Jimmy where are you? We have one of your BOOM days !

Added a few more this am I think the DoseMe Rx is a game changer .

Likewise Andrew I'm currently holding over 1% and have no intention of selling!

People still are though IG. We might see 5p again today

Laura I don't think we need to be speculative. PYC is undervalued but the market is where it is at present ( poised to breakout ) . Let's wait for the next contract win and update either one of which is likely to be very soon. The Board are clearly aware as never before of the need to keep shareholders in the loop and the importance of news flow. The expansion of their corporate objectives is really good news and once factored in will undoubtedly see a rerate of the share price. Many of us have waited a long time for the company to mature. It is now fast approaching that point and I have no doubt that the current CEO will endeavour to manage significant growth in the short to medium term. It's good to see more interest in the shares of late. That said I do agree with your assertion that a successful outcome to a Dosing App would be a massive bonus that could well present further opportunities. What is abundantly clear is that the Board appreciate market perception and trust need to be better understood and restored and are.

DeBull You are quite right of course, but buying is not that easy at present. Try a buy or two yourself just to check the market.

Hi I've been sold on the technology for years Laura. Systems Biology/Physiomics was in its infancy over 20 years ago. Laura, The main reason its adoption has been so slow ( not just limited to PYC ) is that tried and tested animal models have always ( up until quite recently) been the only way to steer a passage through the well charted waters ( procedural requirements) of The FDA , MRHA et al. During this time we have witnessed all else in computers including and not limited to drug discovery and rational drug design.

I believe that the new CEO is a force for good, he appears to display much needed enthusiasm something that has been lacking in his predecessors . The original aim was to create working tools/models, for the deliverance of Personalised Medicine and dosing regimes. It looks as though (Not before time) this will now become a reality. Lets hope so The market sector presents a uniquely massive opportunity to successful participants.

As with everything associated with drug development and discovery it takes time to garner support and acceptance for new technologies. Over a 100 projects later and we are beginning to see the kind of peer group acceptance of PYC's tech. It can only be for the good It speaks volumes to me!

It will only happen as traction and confidence in their technology grows and the need to use it to comply with regulatory requirements . There after it will the subject of their negotiating skills which are currently under the microscope and far from the best tool in their portfolio! Just my opinion but hopefully their confidence to put in deal making clauses will increase away from a lets do a deal at all costs mentality. They are saving bio's and small pharma cos significant amounts of expenditure in areas where attrition is greatest. Its looking good and long overdue!

Got to say I think his presentation was very good. I believe he's genuinely capable of taking PYC into profit and look forward to the development of Biostats and Personalised Medicine. The latter was always something that was clearly within their remit but has taken a long time to gain any form of traction. The rise in Regulatory requirements ( long overdue ) for non animal thus computer based modelling presents some very significant opportunities for the company. I believe 2024 will be a watershed in their development and subsequent success. Looking for innovative routes to royalty sharing should also be advanced. As always good luck!

How good to read your post!

On this very point I recall reading on one bulletin board some time ago ( apologies I cannot which one ) that One chap ( an absolute idiot!, said as soon as he sold any shares in a company, the price went up! As it happened so many times he decided to sell a few at a time in an attempt to beat the system But needless to say he got it wrong yet again. Selling and hindsight are always talking points This will recover if for no reason other than The Company is good and they have news flow that most assert is going to be very positive. Have a great Easter.

Don't knock yourself there were very few sales above 5p and the price will soon recover . The best is yet to come sit tight and watch you'll get another chance for certain!

No I am definitely not advocating selling I'M holding! W51 I just thought that someone might have bought when the intended to sell. Too much news to come in the short term to be selling . Another good day and more to follow!

Looks like someone pushed the wrong button a costly error if so!

Agreed and definitely confusing! Price adjustment has cleared the confusion though!

Molotov what on earth will you get if the result is a 5000+ barrels a day? Don't be too explicit ! LoL At least we can smile today, tomorrow is promised to no one!

Bit Premature sorry Jimmy!